Ken Griffin PhaseBio Pharmaceuticals Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$0.957

Avg closing price
Price range
Ken Griffin Portfolio Stock Details (PHAS)

9 Ken Griffin PhaseBio Pharmaceuticals Trades

The first PhaseBio Pharmaceuticals trade was made in Q2 2020. Since then Ken Griffin bought shares three more times and sold shares on five occasions. The investor sold all their shares in Q3 2022 and doesn't own any shares in PhaseBio Pharmaceuticals anymore.

Avg closing price
Price range
Sold -108k shares Q3 2022
Avg closing price $1.02
Price range $0.18 - $1.35
New holding (+108k shares) Q2 2022
Avg closing price $0.96
Price range $0.52 - $1.59
Sold -37.5k shares Q1 2022
Avg closing price $1.62
Price range $0.97 - $2.66
Increased shares by 169.3% (+23.5k shares) Q4 2021
Avg closing price $3.02
Price range $1.90 - $4.05
Sold 65.6% shares (-26.5k shares) Q3 2021
Avg closing price $3.34
Price range $2.72 - $3.85
Increased shares by 194.3% (+26.7k shares) Q2 2021
Avg closing price $3.33
Price range $2.70 - $3.98
Sold 11.6% shares (-1.8k shares) Q1 2021
Avg closing price $4.06
Price range $3.25 - $5.54
Sold 0.9% shares (-137 shares) Q3 2020
Avg closing price $4.03
Price range $3.17 - $5.49
New holding (+15.7k shares) Q2 2020
Avg closing price $4.43
Price range $2.85 - $6.02
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!